Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2026 it was -¥152.39B, down 241.2% from the year before. The highest annual figure on record is ¥376.01B in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -¥152.39B | -241.2% |
| FY2025 | Mar 31, 2025 | ¥107.93B | -25.1% |
| FY2024 | Mar 31, 2024 | ¥144.07B | -54.6% |
| FY2023 | Mar 31, 2023 | ¥317.02B | +37.8% |
| FY2022 | Mar 31, 2022 | ¥230.06B | -38.8% |
| FY2021 | Mar 31, 2021 | ¥376.01B | +749.9% |
| FY2020 | Mar 31, 2020 | ¥44.24B | -67.3% |
| FY2019 | Mar 31, 2019 | ¥135.19B | -27.7% |
| FY2018 | Mar 31, 2018 | ¥186.89B | +62.6% |
| FY2017 | Mar 31, 2017 | ¥114.94B | – |